Developing potent urate transporter inhibitors: compounds designed for their uricosuric action

    公开(公告)号:US10005750B2

    公开(公告)日:2018-06-26

    申请号:US13823522

    申请日:2011-10-06

    CPC classification number: C07D307/84 C07D209/12 C07D307/79 C07D307/80

    Abstract: A compound represented by the general Formula I: a pharmaceutically acceptable salt or ester thereof, a solvate thereof, a chelate thereof, a non-covalent complex thereof, a pro-drug thereof, a deuterated radio-labeled analog thereof, and mixtures of any of the foregoing, wherein: A-K are individually selected from carbon or nitrogen; X═—O, —NR1, or —S; R1-11 are individually selected from the group consisting of —H, C1-C6 alkyl, C6-C14 aryl, substituted C6-C14 aryl, C1-C14-alkoxy, halogen, hydroxyl, carboxy, cyano, C1-C6-alkanoyloxy, C1-C6-alkylthio, C1-C6-alkylsulfonyl, trifluoromethyl, hydroxy, C2-C6-alkoxycarbonyl, C2-C6-alkanoylamino, —O—R12, S—R12, —SO2—R12, —NHSO2R12 and —NHCO2R12, wherein R12 is phenyl, naphthyl, or phenyl or naphthly substituted with one to three groups selected from C1-C6-alkyl, C6-C10 aryl, C1-C6-alkoxy and halogen, and C4-C20 hydroxyheteroaryl wherein the heteroatoms are selected from the group consisting of sulfur, nitrogen, and oxygen.

    BENZOFURAN DERIVATIVES FOR THE TREATMENT OF HEPATITIS C
    7.
    发明申请
    BENZOFURAN DERIVATIVES FOR THE TREATMENT OF HEPATITIS C 有权
    用于治疗乙型肝炎的苯唑嘌呤衍生物C

    公开(公告)号:US20150141395A1

    公开(公告)日:2015-05-21

    申请号:US14387883

    申请日:2013-03-26

    Inventor: Kap-Sun Yeung

    CPC classification number: C07D405/14 A61K31/506 A61K45/06 C07D307/84

    Abstract: The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.

    Abstract translation: 本公开提供式I化合物,包括其盐,以及使用该化合物的组合物和方法。 该化合物具有抗丙型肝炎病毒(HCV)的活性,可用于治疗HCV感染者。

Patent Agency Ranking